Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV

Current coronavirus disease 2019 (COVID-19) mRNA vaccines induce robust SARS-CoV-2-specific humoral and cellular responses in people with HIV (PWH). However, the rate of decay of effector immune responses has not been studied in these individuals. Here, we report a significant waning of antibody responses but persistent T-cell responses 6 months post vaccination in virally suppressed PWH with high CD4 + T-cell counts. These responses are comparable with those seen in healthy donors.